TO THE EDITOR Acne inversa (AI; also known as hidradenitis suppurativa; OMIM #142690) is an autosomal dominantly inherited skin disorder characterized by recurrent draining sinuses and abscesses with subsequent scarring and chronic seepage. It mainly affects the scalp, neck, the axillae, perineum, and inframammary regions, which may lead to social embarrassment and have a profound impact on the quality of life. Its prevalence has been estimated to be 1-4% (Danby and Margesson, 2010) . Our previous studies have already discovered that the genetic locus responsible for AI is located at chromosome 1p21.1-1q25.3 by genomewide linkage scan in a four-generation Chinese family (Gao et al., 2006) .
Recently, exome sequencing has been demonstrated to be a powerful and cost-effective strategy for identifying the responsible genes of rare monogenic disorders (Ng et al., 2009 Hoischen et al., 2010) . Here, we subjected the exomes of two affected (II4 and III8) and an unaffected (III7) individual in our previously mapped kindred (Family 1) to exome sequencing. Informed consent was obtained from all sequenced individuals. This study was approved by the ethics committee of Anhui Medical University and was conducted according to Declaration of Helsinki principles. Exome capture was carried out using Agilent SureSelect Human All Exon Kit (in solution; Santa Clara, CA) guided by the manufacturer's protocols. Each captured library was then loaded on Hiseq2000 platform (Illumina, San Diego, CA) and paired-end sequencing was Abbreviation: AI, acne inversa performed, with read lengths of 90 bp, providing at least 50 average depths for each sample. Raw image files were processed by Illumina Basecalling Software 1.7 (San Diego, CA) for basecalling with default parameters. Sequence reads in each individual were aligned to human reference genome builds hg18 using SOAPaligner 2.20 (Li et al., 2009b) . The consensus genotypes in target regions were called by using SOAPsnp(v1.03) (Li et al., 2009a) .
LETTER TO THE EDITOR
On average, 10.36 Gb of sequence was generated per individual as pairedend, 90-bp reads. After discarding the reads that had duplicated start sites, we achieved B50-fold coverage of the 2.2-Gb mappable, targeted exome defined by RefSeq genes (Pruitt et al., 2007) . On average, 87.4% of the exome was covered at least 10-fold, and 42,678 genetic variants were identified per individual, including 34,570 nonsynonymous changes.
To distinguish potentially pathogenic mutations from other variants, we focused on nonsynonymous variants and splice acceptor/donor site mutations (SS), anticipating that synonymous variants would be far less likely to be pathogenic. We also presumed that the variants responsible for AI would be rare and therefore likely to be absent in general population. A novel variant was defined as one that did not exist in the databases used for comparison, including dbSNP129, exome data from eight HapMap individuals sequenced in the previous study (Ng et al., 2009) , 1,000 genomes (Siva, 2008) , the control in the kindred and each group combined. Finally, we found that 85 mutations in 85 candidate genes, respectively, were shared by the two cases, of which eight genes (MYBPHL, KCNC4, FLAD1, NES, NCSTN, ITLN2, SLC9A11, and Clorf220) were located in 1p21.1-1q25.3. Among the eight genes, mutations in NCSTN have been very recently identified in AI (Wang et al., 2010a) . Moreover, with combinatorial filtering supplemented by prediction of ANNOVAR and GERP scores, we successfully tracked down NCSTN as a candidate gene for AI as well (Cooper et al., 2010; Wang et al., 2010b) .
The mutation we found in NCSTN is a splice site mutation (IVS11 þ 1G4A), which is located in position þ 1 of the splice donor site of intron 11 (Supplementary Figure S1 online) and may cause an abnormal splicing event. To validate the mutation, we first tested all the samples in family 1 (9 cases and 12 controls) by Sanger sequencing using an ABI PRISM 3730 automated sequencer (Applied Biosystems, Carlsbad, CA). The 1352 þ 1G4A mutation was confirmed in family 1 (Figure 1a and b) . We then sequenced all the 17 exons and exon-intron boundaries of NCSTN gene in family 2 (5 cases and 8 controls) (Figure 2 ) and found a two-nucleotide deletion c.210_211delAG (p.Thr70fsX18) in NCSTN, which is predicted to change the reading frame after codon 70, creating a new reading frame ending in a stop at position 18 within exon 3 (Figure 1c and d) . These two heterozygous mutations were detected in all available affected individuals in both families, but not in either available unaffected family members or 90 unrelated, population-matched controls.
NCSTN encodes Nicastrin, which is an essential subunit of g-secretase complex. g-Secretase is a transmembrane protease that mediates intramembranous cleavage of various type I membrane proteins, including amyloid precursor protein and Notch. Notch regulates cell fate determination during the differentia- tion of epidermis and hair, and is associated with cyst formation (Yamamoto et al., 2003) . The Notch pathway is a highly conserved and ubiquitous signaling system that is an important form of direct cell-cell communication involved in cell fate determination, stem cell potential, and lineage commitment (Nichols et al., 2007) . Alterations in the Notch pathway lead to epidermal and follicular abnormalities in mouse skin that are histopathologically similar to those observed in human AI (Pan et al., 2004) . Moreover, mutations in other two g-secretase genes (PSENEN, PSEN1) were also identified in AI (Wang et al., 2010a) . All these observations suggested that abnormal g-secretase has a role in the pathogenesis of AI.
To date, most of the genes identified by exome sequencing are for recessive diseases, which are generally easier to find than genes for dominant disorders. Here, we confirmed the gene NCSTN responsible for a rare autosomal dominant disorder AI using only three individuals by combining exome sequencing with previous genome-wide linkage analysis. Our study not only succeeded in presenting a useful and effective method for finding the causative gene of a rare monogenic disorder in small samples, but also advanced our understanding on the genetic basis of AI.
